Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
CALL
ResMed
RMD
$30.8B
| $12.5M | ﹤0.01% |
55,700
+34,500
| +163% | +$8.6M |
2017 Q2
35 quarters
|
|
2902
PUT
Hershey
HSY
$32.2B
| $12.5M | ﹤0.01% |
60,100
-65,900
| -52% | -$13.9M |
2013 Q2
51 quarters
|
|
2903
Appian
APPN
$2.63B
| $12.5M | ﹤0.01% |
518,009
-35,013
| -6% | -$950K |
2024 Q4
5 quarters
|
|
2904
PUT
Truist Financial
TFC
$56.7B
| $12.5M | ﹤0.01% |
271,600
-76,000
| -22% | -$3.76M |
2013 Q2
51 quarters
|
|
2905
CALL
Lincoln National
LNC
$7.72B
| $12.5M | ﹤0.01% |
351,300
+105,100
| +43% | +$4.04M |
2013 Q2
51 quarters
|
|
2906
Ardmore Shipping
ASC
$788M
| $12.5M | ﹤0.01% |
817,041
+352,547
| +76% | +$4.84M |
2019 Q2
27 quarters
|
|
2907
Fidelity Total Bond ETF
FBND
$27.9B
| $12.4M | ﹤0.01% |
+272,762
| New | +$12.6M |
2026 Q1
0 quarters
|
|
2908
PUT
Markel Group
MKL
$21.5B
| $12.4M | ﹤0.01% |
6,500
-2,200
| -25% | -$4.46M |
2020 Q4
21 quarters
|
|
2909
MP Materials
MP
$8.37B
| $12.4M | ﹤0.01% |
+257,413
| New | +$15.4M |
2026 Q1
0 quarters
|
|
2910
PUT
Huntington Ingalls Industries
HII
$10.6B
| $12.4M | ﹤0.01% |
32,700
+3,000
| +10% | +$1.24M |
2013 Q2
51 quarters
|
|
2911
CALL
Herbalife
HLF
$1.32B
| $12.4M | ﹤0.01% |
843,300
+50,200
| +6% | +$820K |
2013 Q2
51 quarters
|
|
2912
CALL
Citizens Financial Group
CFG
$27.1B
| $12.4M | ﹤0.01% |
206,900
+21,200
| +11% | +$1.3M |
2018 Q3
30 quarters
|
|
2913
CALL
Capri Holdings
CPRI
$1.64B
| $12.4M | ﹤0.01% |
703,600
+38,800
| +6% | +$821K |
2013 Q2
51 quarters
|
|
2914
PUT
Caesars Entertainment
CZR
$6.04B
| $12.4M | ﹤0.01% |
468,700
-1,587,700
| -77% | -$37.8M |
2018 Q2
31 quarters
|
|
|
OKLO
2915
Oklo
OKLO
$6.67B
| $12.4M | ﹤0.01% |
249,676
+31,204
| +14% | +$2.24M |
2024 Q2
7 quarters
|
|
2916
CALL
MoonLake Immunotherapeutics
MLTX
$971M
| $12.4M | ﹤0.01% |
664,000
-828,800
| -56% | -$13.7M |
2023 Q3
10 quarters
|
|
2917
CALL
ZIM Integrated Shipping Services
ZIM
$3.57B
| $12.4M | ﹤0.01% |
469,500
-320,800
| -41% | -$7.99M |
2021 Q2
19 quarters
|
|
2918
Kosmos Energy
KOS
$1.49B
| $12.4M | ﹤0.01% |
4,450,077
-1,106,175
| -20% | -$2.08M |
2024 Q4
5 quarters
|
|
2919
CALL
GDS Holdings
GDS
$5.52B
| $12.4M | ﹤0.01% |
306,900
+58,300
| +23% | +$2.5M |
2018 Q2
31 quarters
|
|
2920
PUT
PNC Financial Services
PNC
$88.2B
| $12.4M | ﹤0.01% |
59,400
+7,700
| +15% | +$1.68M |
2013 Q2
51 quarters
|
|
2921
PUT
Magnite
MGNI
$3.55B
| $12.4M | ﹤0.01% |
1,040,000
+279,800
| +37% | +$3.75M |
2019 Q3
26 quarters
|
|
2922
Halozyme
HALO
$12.5B
| $12.3M | ﹤0.01% |
+191,051
| New | +$13.5M |
2026 Q1
0 quarters
|
|
2923
CALL
Vulcan Materials
VMC
$31.5B
| $12.3M | ﹤0.01% |
45,300
+27,400
| +153% | +$8.06M |
2013 Q2
51 quarters
|
|
2924
PUT
Sony
SONY
$139B
| $12.3M | ﹤0.01% |
595,500
+109,400
| +23% | +$2.45M |
2016 Q2
39 quarters
|
|
2925
CALL
CRISPR Therapeutics
CRSP
$5.36B
| $12.3M | ﹤0.01% |
258,900
-319,800
| -55% | -$16.9M |
2018 Q1
32 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.